Skip to content
FrontierPicks

Momentum leaders · current

US momentum leaders — September 2026

As of 18 September 2026

HOWL is up 182.4% over three months, BRR 150.7%, and ASST 102.8%. They do not share a clear sector story: ASST is in financial services, while HOWL and BRR have unknown sector classifications. Leadership appears narrow rather than broad, with 37.0% of stocks above their 200-EMA and deteriorating in a risk-off regime as of 2026-09-18.

# Name 3-mo price move
1
HOWL
+182.4%
2
ASST
+102.8%

Strive, Inc.'s bitcoin-treasury premium thesis depends on increasing bitcoin per diluted common share. A company-reported year-to-date Bitcoin…

3
BRR
+150.7%
4
CHPT
+24.7%
5
CMRC
+22.9%
6
FWDI
+70.1%

Forward Industries' Solana treasury re-rating requires growing tokens per share and a verified recovery to net asset value. Updated disclosure…

7
ALVO
+50.8%

Alvotech's recovery prices in Q4 2026 FDA approvals after the Reykjavik inspection closure announced on 2026-07-29. AVT05 and AVT06 approvals…

8
SDGR
+85.3%

Agentic-AI software leg: the 2026-08-05 Bristol Myers Squibb agreement to deploy Bunsen at scale landed with a double beat (Q2 revenue $58.889M vs…

9
MSTR
+34.8%

Strategy Inc.'s bitcoin accumulation thesis needs successive purchase disclosures and STRC recovering its $100 stated amount. Those milestones…

10
SMTC
+15.0%

The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21,…

11
CVI
+95.1%

CVR Energy’s refining thesis is that Hormuz disruption lifts reported margins above second-quarter 2026’s $9.94 per throughput barrel.…

12
BNGO
+53.5%

Bionano Genomics’ clinical-adoption and reimbursement story supports a test of the $2.13 annual high. A daily close above that level would confirm…

13
AOUT
+62.0%

American Outdoor Brands’ margin recovery supports an earnings-driven rerating toward Roth Capital’s $17 target dated 2026-09-04. A daily close at…

14
BLSH
+58.6%

Bullish's regulatory repricing thesis requires successful CLARITY Act cloture followed by a weekly close above $37.10 before a weekly close below…

15
EBS
−14.3%
16
ODD
+41.2%

Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no…

17
ACVA
+61.7%
18
VRA
+11.0%

Vera Bradley’s September earnings rally prices in a turnaround; a weekly close above the observed $4.26 annual high before a weekly close below…

19
MARA
−6.9%

AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8…

20
FSOL
+64.6%
21
UPXI
+31.1%

Upexi’s Solana-discount recovery requires positive audited net assets and a Nasdaq bid-price cure. The September 28 annual-report checkpoint is…

22
BMEA
+59.7%

Biomea Fusion’s icovamenib thesis depends on lasting glucose control after limited treatment. COVALENT-211 must meet its placebo-controlled…

23
UMC
+2.1%

Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded…

24
SMMT
+28.1%

Summit Therapeutics’ ivonescimab thesis is that quantified survival evidence converts into US approval by 2026-11-14 before a weekly close below…

25
HAFN
+46.8%

Hafnia Limited’s tanker-earnings surge supports a continuation case at its 2026-09-11 high. The 2026-11-18 results test earnings durability, while…

26
TITN
+14.1%

Titan Machinery’s farm-equipment recovery re-rating requires falling total inventory and preserved earnings guidance at its next quarterly report.…

27
BE
−17.5%

Bloom Energy’s AI data-center power thesis now depends on earnings sustaining the September advance after index inclusion. The next quarterly…

28
TRMD
+38.9%

TORM plc’s freight-earnings story supports a conditional move to Evercore ISI’s $38 target, reported on 2026-08-27. The case succeeds at a daily…

29
CNH
+29.0%

CNH Industrial's farm-equipment recovery is being priced ahead of earnings after September's analyst upgrades. The next quarterly report tests…

30
CAI
+62.5%

Caris Life Sciences’ molecular-profiling growth supports another revenue-guidance increase at the next quarterly report. Guidance above the…

31
ECO
+76.3%
32
DELL
+40.3%

Dell Technologies’ AI-server thesis requires roughly $19 billion of next-quarter revenue and infrastructure operating margin of at least 15.0%.…

33
OKTA
+56.0%

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted…

34
SWKS
+22.0%

Skyworks Solutions' Qorvo merger story supports further repricing, with a weekly close above the September 18 high of $91.32 defining success. A…

35
SBET
+74.6%

SharpLink's Ether treasury discount is the recovery thesis: The Block reported a 0.84-times net asset value multiple on 2026-09-07. The case plays…

36
PRE
+17.5%
37
BMNR
+61.6%

Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest…

38
MYGN
−11.2%

Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and…

39
FEIM
+15.9%
40
DPRO
−3.4%

Draganfly's policy-led drone re-rating now has a Canadian defence contract behind it, announced on 2026-09-11. A weekly close above the historical…

41
ANF
+53.9%

Abercrombie & Fitch’s margin re-rating lacks price confirmation after the 2026-09-18 close of $135.76. Continuation requires a weekly close above…

42
TEM
+53.2%

Tempus AI's proposed Personalis acquisition supports a cancer-vaccine sequencing recovery thesis. A daily close above the August 21 reference…

43
GME
+4.9%
44
CLSK
−16.1%

Spring's binary resolved bullish: CleanSpark signed a $6.6B, 20-year Georgia data-center lease (2026-07-14) with an unnamed "global technology…

45
HOOD
+10.4%

Robinhood Markets' September repricing now includes prediction-market infrastructure alongside on-chain finance. Stronger August activity and a…

46
SID
+6.3%

New-CEO deleveraging story: Fabio Schvartsman replaced 24-year CEO Benjamin Steinbruch on 2026-09-03 and the ADR ran from $1.13 (09-01) to $1.22…

47
WGS
+71.0%

Busted-growth genomics name; the recovery off the −49% May guide-cut crash has stalled in the low-$60s, below the $74.83 200-day. The confirmed…

48
TH
+5.0%

The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates…

49
RBLX
−8.1%

Broken growth compounder: the age-verification rollout throttled DAUs and forced FY26 bookings guidance down to +8-12%; stock is -66% from its…

50
PSIX
+14.0%

"3-mo price move" is the stock's market price change, not a FrontierPicks return.

How this board is built

Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closes and ranked highest-first. No model orders the board — the ranking is arithmetic. The "3-mo price move" column is one of the three inputs to that score, weighted 20% — not the ranking itself, so rows do not descend in it. The board reflects price moves already made, not a forecast. Each covered name links to its dated research dossier — thesis, invalidation trigger, archetype and catalyst.

Past months

Each month's board is frozen when the month closes and kept unchanged — the record of what led, when.

Questions

What are the hottest US stocks right now?
As of 18 September 2026, the US names with the strongest composite momentum score on FrontierPicks are HOWL, ASST, BRR, CHPT. This is a momentum ranking of price moves already made — research, not advice.
How is this momentum ranking built?
Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closes, then ranked highest-first. The arithmetic is the whole ranking — no model orders the board. Each covered name links to its dated research dossier. Methodology is open.
Is a high ranking a recommendation?
No. The board reflects price moves that have already happened, not a forecast or a recommendation. It is educational research, not investment advice.

As of 18 September 2026 · research, not advice.